Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/12/2025

Substance Abuse Evaluation and Management

Patient Education and Risk Assessment

  • The American Psychiatric Association recommends informing patients about the risk of dependence and symptoms of withdrawal when prescribing gabapentin, as stated by a guideline from a reputable society similar to the American College of Psychiatry 1
  • Patients with current or past substance use disorders are at significantly higher risk for gabapentin misuse and dependence 1
  • Repeated exposure to gabapentin can result in tolerance, where the same dose produces diminishing effects over time, potentially increasing the risk of dependence, similar to opioids 2
  • Evaluate patients for history of substance abuse before prescribing gabapentin, and observe for signs of misuse including self-dose escalation and drug-seeking behavior, as recommended by 1, 2

Gabapentin Withdrawal Management

  • A gradual tapering approach is essential when discontinuing gabapentin, with gradual reduction over weeks to months rather than abrupt discontinuation, as recommended by The Lancet Psychiatry and supported by 1, 2, 3
  • The American Academy of Neurology and other medical societies recommend managing gabapentin withdrawal symptoms through a careful, gradual tapering schedule over weeks to months rather than abrupt discontinuation to minimize potentially severe withdrawal effects 3
  • Common gabapentin withdrawal symptoms include agitation, disorientation, confusion, anxiety, insomnia, nausea, vomiting, diarrhea, sweating, tachycardia, and potential for seizures in patients with or without a seizure history 1
  • Patients with a history of substance use disorders require a more cautious approach to gabapentin tapering due to a higher risk of severe withdrawal 1, 3
  • Elderly patients may need even more gradual tapering due to increased sensitivity to withdrawal effects, as suggested by the Mayo Clinic Proceedings and The Lancet Psychiatry 1, 3
  • Patients with seizure disorders require especially careful monitoring due to the risk of seizure recurrence during withdrawal 1

Pharmacological Management of Gabapentin Withdrawal

  • Clonidine or tizanidine (α2-Agonists) can attenuate gabapentin withdrawal symptoms, with clonidine used cautiously due to hypotension risk, as suggested by the Mayo Clinic Proceedings 3
  • Trazodone may help with insomnia during gabapentin withdrawal, according to the Mayo Clinic Proceedings 3
  • Tricyclic antidepressants may help manage gabapentin withdrawal symptoms, as noted in the Mayo Clinic Proceedings 3
  • Loperamide can be used for gastrointestinal discomfort during gabapentin withdrawal, with monitoring for misuse, as recommended by the Mayo Clinic Proceedings 3